Phibro Animal Health Corporation Reports Third Quarter
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Guggenheim Cuts Price Target on Phibro Animal Health (PAHC) Following 3Q Miss
May 10, 2016 2:06 PM EDTGuggenheim maintained a Buy rating on Phibro Animal Health Corp. (NASDAQ: PAHC), and cut the price target to $26.00 (from $34.00), following the company's 3Q earnings report. PAHC reported F'3Q16 EPS of $0.38, $0.03 lower than consensus. PAHC lowered its F'16 revenue and EPS guidance to $745MM-$750MM, and... More
Phibro Animal Health (PAHC) Misses Q3 EPS by 5c; Trims FY16 Outlook
May 9, 2016 4:19 PM EDTPhibro Animal Health (NASDAQ: PAHC) reported Q3 EPS of $0.38, $0.05 worse than the analyst estimate of $0.43. Revenue for the quarter came in at $183 million versus the consensus estimate of $197.24 million.
GUIDANCE:
Phibro Animal Health sees FY2016 EPS of $1.58-$1.60, versus the... More
